(Press-News.org) Stop using racial profiling, says Professor William Press from the University of Texas at Austin. He claims that as well as being politically and ethically questionable, racial profiling does no better in helping law enforcement officials in their task of catching terrorists than standard uniform random sampling techniques. This is the topic of a paper publishing today in Significance, the magazine of the Royal Statistical Society and the American Statistical Association.
Racial profiling rests on the idea that people from particular racial or ethnic groups are more likely to be involved in acts of terror than people from other groups. The theory then suggests that law enforcement officers should spend a greater proportion of their time scrutinising people from the 'high risk' group. One problem with this approach is that innocent people who also belong to the targeted group rapidly become offended, and some may even become radicalised as a result.
"Racial profiling is as indiscriminate as deciding that people named Patrick are more likely to drink and drive, and so everyone who is named Patrick should be stopped and breathalysed more frequently than people with other names," says Press. Although it may be the case that some people named Patrick do drink and drive, he points out that there are clear problems in this profiling strategy. First, many Patricks don't drink and drive and will be unfairly detained. Secondly, this sort of profiling can have the appearance of success because if you keep testing more people named Patrick than other people, you are almost bound to find more Patricks who have drunk alcohol than people with other names. This then leads you to think the problem is even worse than you first suspected, and so you further increase the targeting of Patricks.
In the Significance paper Press, based in the departments of Computer Science and Integrative Biology at the University of Texas at Austin, takes a thorough mathematical and statistical view of the process that underlies racial profiling, and concludes that some forms of racial profiling may even result in a smaller chance of detaining a terrorist than carefully conducted standard sampling.
In a world threatened by terrorists from a small number of countries, it is tempting to think that racial profiling for security purposes, even if morally objectionable, might save lives. "But uniform sampling, without the use of profiling, is surprisingly good. It is robust against false assumptions, it is deterrent, it is easy to implement, it is about as effective as any real-life system can be – and it is devoid of moral and political hazard," says Press.
He believes that the choice between a strategy of profiling and one of uniform random sampling should not be viewed as difficult; uniform random sampling wins.
INFORMATION: END
Racial profiling to limit terror attacks is fundamentally flawed
2010-11-18
ELSE PRESS RELEASES FROM THIS DATE:
Regenerative stem cell therapy offers new hope for treating cardiovascular disease
2010-11-18
Northwestern Medicine physician researchers are revolutionizing treatment of cardiovascular disease by utilizing patients' own stem cells to regenerate heart and vascular tissue. Northwestern Medicine is the lead site for a study examining stem cell transplantation as treatment for critical limb ischemia. Chief investigator Douglas Losordo, MD, director of the Program in Cardiovascular Regenerative Medicine at Northwestern Memorial Hospital and the Eileen M. Foell Professor of Heart Research of Northwestern University's Feinberg School of Medicine, will present the findings ...
Caltech physicists demonstrate a four-fold quantum memory
2010-11-18
PASADENA, Calif. — Researchers at the California Institute of Technology (Caltech) have demonstrated quantum entanglement for a quantum state stored in four spatially distinct atomic memories.
Their work, described in the November 18 issue of the journal Nature, also demonstrated a quantum interface between the atomic memories—which represent something akin to a computer "hard drive" for entanglement—and four beams of light, thereby enabling the four-fold entanglement to be distributed by photons across quantum networks. The research represents an important achievement ...
New drug targets vitamin D receptors in hormone resistant prostate cancers
2010-11-18
A new anti-cancer drug aimed at vitamin D receptors on cancer cells has prompted encouraging responses in the levels of PSA (prostate specific antigen) in men with prostate cancer that has become resistant to hormonal therapies.
Results of the phase II(a) clinical trial will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Thursday). The trial found that when the new drug, inecalcitol, was combined with the existing, current therapy (docetaxel and prednisone) 83% of patients responded to the treatment ...
Tiny Trojan horses attack brain cancer cells
2010-11-18
Scientists in Germany have developed a way of smuggling an anti-cancer drug past the protective blood-brain barrier and into brain tumours and metastases using a nanocarrier – a tiny capsule specially designed to pass through cell membranes and deliver its anti-cancer drug to the cancer cell.
The blood-brain barrier is formed by a network of closely sealed endothelial cells in the brain's capillaries, and it expresses a high level of proteins that pump foreign molecules away from the brain, while allowing others (such as glucose and insulin) that are necessary to the ...
Researchers trap antimatter atoms
2010-11-18
In the movie Angels and Demons, scientists have solved one of the most perplexing scientific problems: the capture and storage of antimatter. In real life, trapping atomic antimatter has never been accomplished, until now.
A team made up of researchers from the University of Calgary, institutions across Canada and around the world have discovered how to trap atomic antimatter and the results of their discovery is published in the journal Nature.
"This is a major discovery. It could enable experiments that result in dramatic changes to the current view of fundamental ...
PARP inhibitor, MK-4827, shows anti-tumor activity in first trial in humans
2010-11-18
A new drug that targets proteins responsible for helping cancer cells to repair damage to their DNA has shown promising anti-tumour activity in its first trial in humans. Some patients with a range of solid tumours, many of whom had been treated unsuccessfully for their cancer with other therapies, have seen their tumours shrink or stabilise for periods of between 46 days to more than a year. The research will be presented at the 22nd EORTC-NCI-AACR [1] Symposium on Molecular Targets and Cancer Therapeutics in Berlin today (Thursday).
Laboratory studies of the drug, MK-4827, ...
NIH experts describe influenza vaccines of the future
2010-11-18
WHAT:
In a review article appearing in the New England Journal of Medicine, scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine research under way to address the limitations of currently available influenza vaccines and develop more efficient and reliable strategies to make vaccines to protect against seasonal as well as pandemic influenza. Although licensed seasonal flu vaccines safely and effectively protect most people who receive them from illness and death, the degree of protection varies ...
Structure of Lassa virus protein reveals viral thievery
2010-11-18
Scientists at Emory University and the University of St. Andrews have solved the structure of a key protein from Lassa virus, which is endemic to West Africa and can cause a deadly hemorrhagic fever.
The structure reveals how the virus evades its host's immune system, and how it hijacks infected cells' vital machinery in a process scientists call "cap-stealing." Details of the structure could guide future efforts at antiviral drug discovery and vaccine development.
The results are published in this week's issue of Nature.
Lassa virus represents a family of viruses ...
Nation's top hospital organ transplant centers identified by HealthGrades
2010-11-18
GOLDEN, Colo. (November 17, 2010) – HealthGrades, the nation's leading independent ratings organization, today made available to organ transplant patients a list of those hospitals with the best track record for survival and chances of receiving a donor organ. HealthGrades annual evaluation of the nation's top-performing hospitals in organ transplantation includes clinical quality data, based on patient outcomes, for each of the 210 adult acute care hospitals that perform transplants. This information is available, free to the public, at HealthGrades.com and is intended ...
Multidisciplinary approach is key to successful treatment of aggressive prostate cancer
2010-11-18
PHILADELPHIA – A research team from the National Cancer Institute (NCI) designated Kimmel Cancer Center (KCC) at Jefferson has concluded – for the first time – that a multidisciplinary clinic approach to aggressive prostate cancer can improve survival in patients. The results from the 15-year study of the multidisciplinary clinic can be found in the November issue of Journal of Oncology Practice.
Stats and Treatment
Prostate cancer remains the most common non-skin cancer and the second leading cause of cancer death in men in the United States. In fact, about 218,000 ...